The Yellow Fever Vaccine Journey: Milestones and Future Directions

Yellow fever, a mosquito-borne viral hemorrhagic disease, remains a significant public health concern in endemic regions of Africa and South America. The development of the yellow fever vaccine marked a milestone in virology and immunization. In the 1930s, Max Theiler created the 17D live-attenuated vaccine, a breakthrough that has achieved global recognition and continues to underpin prevention strategies. This review outlines the historical evolution of the yellow fever vaccine, highlighting pivotal scientific advances, technological innovations, and global eradication initiatives. It examines the current landscape of immunization, focusing on the World Health Organization's Eliminate Yellow Fever Epidemics (EYE) strategy, ongoing efforts to address vaccine supply constraints, and persistent surveillance gaps. Future directions in vaccine development, including next-generation platforms and improved delivery systems, are also discussed, alongside the need for sustained research investment and international collaboration. As yellow fever emerges in previously non-endemic areas due to climate change and globalization, strengthening vaccination programs remains critical to preventing outbreaks and ensuring effective disease control.

Authors

Institutions

Publication Details

Journal
Vaccines
Published
2026-01-05
DOI
https://doi.org/10.3390/vaccines14010065
Citations
2
Primary Topic
Mosquito-borne diseases and control
Type
article
Field-Weighted Citation Impact
83.69

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Yellow Fever Vaccine Journey: Milestones and Future Directions

Lysien I. Zambrano, Pooja Jaiswal, Jaime David Acosta-España, Preeti Gupta et al.
2 citations
Vaccines
Mosquito-borne diseases and control
83.69
article

The Yellow Fever Vaccine Journey: Milestones and Future Directions

Lysien I. Zambrano, Pooja Jaiswal, Jaime David Acosta-España, Preeti Gupta, Aroop Mohanty, Juan Pablo Hernández-Ovalle, Shriyansh Srivastava, Alfonso J. Rodríguez-Morales, Sanjit Sah, Mohd Tariq, Nandani Jayaswal, Sathvik Belagodu Sridhar, Rachana Mehta, G. S. N. Koteswara Rao
article en
2 citations

Abstract

Yellow fever, a mosquito-borne viral hemorrhagic disease, remains a significant public health concern in endemic regions of Africa and South America. The development of the yellow fever vaccine marked a milestone in virology and immunization. In the 1930s, Max Theiler created the 17D live-attenuated vaccine, a breakthrough that has achieved global recognition and continues to underpin prevention strategies. This review outlines the historical evolution of the yellow fever vaccine, highlighting pivotal scientific advances, technological innovations, and global eradication initiatives. It examines the current landscape of immunization, focusing on the World Health Organization's Eliminate Yellow Fever Epidemics (EYE) strategy, ongoing efforts to address vaccine supply constraints, and persistent surveillance gaps. Future directions in vaccine development, including next-generation platforms and improved delivery systems, are also discussed, alongside the need for sustained research investment and international collaboration. As yellow fever emerges in previously non-endemic areas due to climate change and globalization, strengthening vaccination programs remains critical to preventing outbreaks and ensuring effective disease control.

VaccinesVol. 14(1)
Galgotias University (IN), Korea University (KR), Narsee Monjee Institute of Management Studies (IN), Universidad Científica del Sur (PE), Pontificia Universidad Católica del Ecuador (EC), Dr. D. Y. Patil Medical College, Hospital and Research Centre (IN), Dr. D.Y. Patil Vidyapeeth, Pune (IN), Suamandeep Vidyapeeth University (IN), National Autonomous University of Honduras (HN), NLR Nepal (NP), Institución Universitaria Visión de las Américas (CO), Korea University (JP), Dr D Y Patil Dental College & Hospital (IN), Universidad Internacional SEK (EC), Manav Rachna International Institute of Research and Studies (IN), Graphic Era University (IN), All India Institute of Medical Sciences (IN), Friedrich Schiller University Jena (DE), Ras al-Khaimah Medical and Health Sciences University (AE), Deen Dayal Upadhyaya Gorakhpur University (IN)
Agenzia Spaziale Italiana, Universidad Nacional Autonoma de Honduras
Partnerships for the goals
Openalex Percentile: Top 0%
Mosquito-borne diseases and control
83.69
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.